What is the share price of Decipher Labs Ltd (DECIPHER) today?
The share price of DECIPHER as on 18th September 2026 is ₹5.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Decipher Labs Ltd (DECIPHER) share?
The past returns of Decipher Labs Ltd (DECIPHER) share are- Past 1 week: 2.80%
- Past 1 month: -6.78%
- Past 3 months: -11.29%
- Past 6 months: -10.57%
- Past 1 year: -48.26%
- Past 3 years: -69.70%
- Past 5 years: -84.01%
What are the peers or stocks similar to Decipher Labs Ltd (DECIPHER)?
The peers or stocks similar to Decipher Labs Ltd (DECIPHER) include:What is the market cap of Decipher Labs Ltd (DECIPHER) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Decipher Labs Ltd (DECIPHER) is ₹5.55 Cr as of 18th September 2026.What is the 52 week high and low of Decipher Labs Ltd (DECIPHER) share?
The 52-week high of Decipher Labs Ltd (DECIPHER) is ₹11.20 and the 52-week low is ₹5.What is the PE and PB ratio of Decipher Labs Ltd (DECIPHER) stock?
The P/E (price-to-earnings) ratio of Decipher Labs Ltd (DECIPHER) is -1.80. The P/B (price-to-book) ratio is 0.24.Which sector does Decipher Labs Ltd (DECIPHER) belong to?
Decipher Labs Ltd (DECIPHER) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Decipher Labs Ltd (DECIPHER) shares?
You can directly buy Decipher Labs Ltd (DECIPHER) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Decipher Labs Ltd
DECIPHER Share Price
BSE₹5.500.18% (-0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
DECIPHER Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
DECIPHER Performance & Key Metrics
DECIPHER Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -1.80 | 0.24 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
DECIPHER Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
DECIPHER Company Profile
Decipher Labs Limited manufactures and markets pharmaceuticals and allied products, providing consultancy and IT services to various formulators and manufacturers.
SUNPHARMA
PE Ratio
38.40
38.40
1Y Return
11.45%
11.45%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
85.10
85.10
1Y Return
35.67%
35.67%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.96
22.96
1Y Return
10.70%
10.70%
Buy Reco %
55.56
55.56
CIPLA
PE Ratio
29.04
29.04
1Y Return
11.64%
11.64%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
118.79
118.79
1Y Return
111.64%
111.64%
Buy Reco %
58.33
58.33
DECIPHER Forecast
DECIPHER Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
DECIPHER
DECIPHER
Income
Balance Sheet
Cash Flow
Quarterly Normal View
DECIPHER Income Statement
DECIPHER Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10.86 | 7.60 | 5.99 | 5.97 | 4.37 | 2.93 | 4.33 | 3.23 | 3.78 | 2.51 | ||||||||||
Operating & Other expenses | 9.38 | 6.13 | 7.20 | 6.44 | 10.08 | 6.24 | 4.19 | 3.64 | 3.38 | 4.57 | ||||||||||
EBITDA | 1.48 | 1.47 | -1.21 | -0.47 | -5.71 | -3.31 | 0.14 | -0.41 | 0.40 | -2.06 | ||||||||||
| Depreciation/Amortization | 0.11 | 0.11 | 0.12 | 0.12 | 0.13 | 0.12 | 0.13 | 0.13 | 0.15 | 0.13 | ||||||||||
| PBIT | 1.37 | 1.36 | -1.33 | -0.59 | -5.84 | -3.43 | 0.01 | -0.54 | 0.25 | -2.19 | ||||||||||
| Interest & Other Items | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 1.16 | 1.36 | -1.33 | -0.59 | -5.84 | -3.43 | 0.01 | -0.54 | 0.25 | -2.19 | ||||||||||
| Taxes & Other Items | -0.04 | 0.41 | 0.00 | 0.01 | -1.73 | 0.00 | 0.00 | 0.01 | 0.61 | 0.00 | ||||||||||
| Net Income | 1.20 | 0.95 | -1.33 | -0.60 | -4.11 | -3.43 | 0.01 | -0.55 | -0.36 | -2.19 | ||||||||||
| EPS | 1.19 | 0.94 | -1.31 | -0.59 | -4.07 | -3.39 | 0.02 | -0.53 | -0.35 | -2.16 |
DECIPHER Company Updates
DECIPHER Stock Peers
DECIPHER Past Performance & Peer Comparison
DECIPHER Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Decipher Labs Ltd | -1.80 | 0.24 | — |
| Sun Pharmaceutical Industries Ltd | 38.40 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 85.10 | 10.47 | 0.70% |
| Zydus Lifesciences Ltd | 22.96 | 3.91 | 0.09% |
DECIPHER Stock Price Comparison
Compare DECIPHER with any stock or ETFCompare DECIPHER with any stock or ETF
DECIPHER
DECIPHER Holdings
DECIPHER Shareholdings
DECIPHER Promoter Holdings Trend
DECIPHER Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
DECIPHER Institutional Holdings Trend
DECIPHER Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
DECIPHER Shareholding Pattern
DECIPHER Shareholding Pattern
DECIPHER Shareholding History
DECIPHER Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing DECIPHER stock
smallcases containing DECIPHER stock
Looks like this stock is not in any smallcase yet.
DECIPHER Events
DECIPHER Events
DECIPHER Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
DECIPHER has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
DECIPHER Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
DECIPHER has not given any dividends in last 5 years
DECIPHER Dividends
DECIPHER Dividends
Hmm, looks like data is unavailable here. Please come back after some timeDECIPHER Stock News & Opinions
DECIPHER Stock News & Opinions
Articles & Videos
Earnings
Earnings
Decipher Labs Ltd consolidated sales down 33.06% on year in Q2FY2026, net profit saw a strong growth of 508.33%Decipher Labs Ltd share price slipped 1.39% to Rs 6.4 after the company's net profit jumped 508.33% to Rs 2.19 crore, while revenue from operations nosedived 33.06% to Rs 2.41 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, gaining 4.59%. It has improved by 0.97% over last one week and heading higher by 11.17% in last one month while the market capitalization of Decipher Labs Ltd has marginally improved by 4.87% and 14.78% in the same period respectively. Profit before tax (PBT) of Decipher Labs Ltd stood at Rs 2.19 crore in Q2 FY26, tanking 35.96% year-on-year, and crashing by 976.00% quarter-on-quarter. EBITDA came in at Rs 2 crore, nosediving by 32.23% YoY and tumbling by 3850.00% sequentially. Total expenses witnessed a sharp rise of 33.14% to Rs 4.7 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 2.76 crore, inching up 2.99% YoY. For the TTM ended FY26, revenue from operations sank 36.98% to Rs 22.61 crore, while net profit soared by 202.38% to Rs 5.08 crore, compared to previous TTM. EBITDA saw a sharp decline of 235% to Rs 8.54 crore, and PBT soared 428.10% to Rs 6.39 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 9.82 crore in FY26, as against Rs 4.85 crore in FY25. Decipher Labs Ltd nosedived by 40.02% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.83% during the same period.
1 month agoCapital Market - Live
Earnings
Earnings
Decipher Labs reports consolidated net loss of Rs 0.36 crore in the March 2026 quarterNet Loss of Decipher Labs reported to Rs 0.36 crore in the quarter ended March 2026 as against net loss of Rs 4.11 crore during the previous quarter ended March 2025. Sales rose 2.86% to Rs 3.60 crore in the quarter ended March 2026 as against Rs 3.50 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 3.08 crore in the year ended March 2026 as against net loss of Rs 5.08 crore during the previous year ended March 2025. Sales declined 37.86% to Rs 14.05 crore in the year ended March 2026 as against Rs 22.61 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales3.603.50 3 14.0522.61 -38 OPM %6.39-188.00 --24.13-31.98 - PBDT0.40-5.71 LP -3.17-5.91 46 PBT0.25-5.83 LP -3.68-6.39 42 NP-0.36-4.11 91 -3.08-5.08 39 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Decipher Labs to table resultsDecipher Labs will hold a meeting of the Board of Directors of the Company on 30 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Decipher Labs reports consolidated net loss of Rs 0.54 crore in the December 2025 quarterNet Loss of Decipher Labs reported to Rs 0.54 crore in the quarter ended December 2025 as against net loss of Rs 0.59 crore during the previous quarter ended December 2024. Sales declined 44.66% to Rs 3.21 crore in the quarter ended December 2025 as against Rs 5.80 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3.215.80 -45 OPM %-13.40-10.86 - PBDT-0.41-0.46 11 PBT-0.53-0.58 9 NP-0.54-0.59 8 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Decipher Labs to convene board meetingDecipher Labs will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Decipher Labs schedules EGMDecipher Labs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 February 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Earnings
Decipher Labs reports consolidated net profit of Rs 0.02 crore in the September 2025 quarterNet profit of Decipher Labs reported to Rs 0.02 crore in the quarter ended September 2025 as against net loss of Rs 1.33 crore during the previous quarter ended September 2024. Sales declined 26.58% to Rs 4.31 crore in the quarter ended September 2025 as against Rs 5.87 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales4.315.87 -27 OPM %2.78-22.66 - PBDT0.14-1.21 LP PBT0.02-1.33 LP NP0.02-1.33 LP Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Decipher Labs to announce Quarterly ResultDecipher Labs will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Decipher Labs to conduct AGMDecipher Labs announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Earnings
Earnings
Decipher Labs reports consolidated net loss of Rs 3.43 crore in the June 2025 quarterNet loss of Decipher Labs reported to Rs 3.43 crore in the quarter ended June 2025 as against net profit of Rs 0.95 crore during the previous quarter ended June 2024. Sales declined 60.75% to Rs 2.92 crore in the quarter ended June 2025 as against Rs 7.44 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales2.927.44 -61 OPM %-113.7017.61 - PBDT-3.311.47 PL PBT-3.421.36 PL NP-3.430.95 PL Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -23.98%, vs industry avg of 11.76%
Over the last 5 years, market share decreased from 0.02% to 0%